Bristol-Myers Squibb: Will Earnings Surprise Wall Street?

Will Bristol-Myers Squibb beat expectations AGAIN? The biopharma giant is set to release its Q3 results on October 30th, and analysts predict a profit of $1.60 per share, an 11% drop from last year. Despite a rocky year with shares down 17%, the stock could surge 20% based on a $53 average target price. Is it time to buy, hold, or sell? Tune in to find out what the experts are saying about Bristol-Myers Squibb's future.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.